Related Experiment Videos
Failure to detect circulating immune complexes in allergic patients on injection therapy
Clinical Allergy
|September 1, 1979
Summary
Injection therapy for allergic diseases does not typically cause circulating immune complexes. A study found that patients receiving allergy injections maintained normal levels of these complexes throughout treatment.
Area of Science:
- Immunology
- Allergology
- Clinical Medicine
Background:
- Allergic diseases are common conditions managed with various therapies.
- Injection therapy for allergies involves administering allergens to induce tolerance.
- Concerns exist regarding potential immune complex formation during this therapy.
Purpose of the Study:
- To investigate the presence of circulating immune complexes in patients undergoing injection therapy for allergic diseases.
- To determine if allergenic injections routinely lead to immune complex formation.
Main Methods:
- Sera from eleven patients receiving allergy injection therapy were analyzed.
- A Raji cell radioimmune assay was employed to detect circulating immune complexes.
- Samples were collected before and at 4, 8, and 24 hours post-injection.
- Results were compared to a control group of forty-two healthy individuals.
Main Results:
- Ten out of eleven patients showed normal levels of circulating immune complexes before injection.
- These patients consistently exhibited normal levels at all measured time points after injection.
- No significant increase in circulating immune complexes was observed in response to allergy injections.
Conclusions:
- Circulating immune complexes are not a common outcome of injection therapy for allergic diseases.
- Current allergy injection protocols appear safe regarding immune complex formation.
- Further research may explore specific patient subgroups or alternative therapies.